BioAdaptives Announces National Launch of Pawpa™ Regen
BioAdaptives (OTC Pink: BDPTD) announced the nationwide launch of Pawpa™ Regen, a revolutionary canine supplement designed to promote regenerative healing through stem cell activation in aging dogs. Following a successful limited market release, the product will be available nationwide through e-commerce platforms by late July 2025.
The proprietary formula works by stimulating the release of circulating stem cells, leading to improvements in vitality, mobility, and overall wellness in older dogs. Early testing has shown positive results in energy levels, coat health, mobility, and temperament. The company is scaling production to meet anticipated strong demand in the pet wellness market.
BioAdaptives (OTC Pink: BDPTD) ha annunciato il lancio a livello nazionale di Pawpa™ Regen, un integratore rivoluzionario per cani progettato per promuovere la guarigione rigenerativa attraverso l'attivazione delle cellule staminali nei cani anziani. Dopo un rilascio limitato e di successo sul mercato, il prodotto sarà disponibile a livello nazionale tramite piattaforme di e-commerce entro la fine di luglio 2025.
La formula proprietaria agisce stimolando il rilascio di cellule staminali circolanti, migliorando vitalità, mobilità e benessere generale nei cani più anziani. I primi test hanno mostrato risultati positivi nei livelli di energia, nella salute del pelo, nella mobilità e nel temperamento. L'azienda sta aumentando la produzione per soddisfare la prevista forte domanda nel mercato del benessere degli animali domestici.
BioAdaptives (OTC Pink: BDPTD) anunció el lanzamiento a nivel nacional de Pawpa™ Regen, un suplemento revolucionario para perros diseñado para promover la curación regenerativa mediante la activación de células madre en perros envejecidos. Tras un exitoso lanzamiento limitado en el mercado, el producto estará disponible a nivel nacional a través de plataformas de comercio electrónico para finales de julio de 2025.
La fórmula patentada funciona estimulando la liberación de células madre circulantes, lo que conduce a mejoras en la vitalidad, movilidad y bienestar general de los perros mayores. Las pruebas iniciales han mostrado resultados positivos en niveles de energía, salud del pelaje, movilidad y temperamento. La empresa está ampliando la producción para satisfacer la fuerte demanda anticipada en el mercado del bienestar para mascotas.
BioAdaptives (OTC Pink: BDPTD)는 노령견의 줄기세포 활성화를 통해 재생 치유를 촉진하는 혁신적인 반려견 보조제 Pawpa™ Regen의 전국 출시를 발표했습니다. 제한된 시장 출시에서 성공을 거둔 후, 이 제품은 2025년 7월 말까지 전자상거래 플랫폼을 통해 전국적으로 판매될 예정입니다.
독자적인 포뮬러는 순환 줄기세포의 방출을 자극하여 노령견의 활력, 이동성 및 전반적인 건강 개선을 도모합니다. 초기 테스트에서는 에너지 수준, 털 건강, 이동성 및 성격에서 긍정적인 결과가 나타났습니다. 회사는 반려동물 웰니스 시장에서 예상되는 강한 수요에 대응하기 위해 생산을 확대하고 있습니다.
BioAdaptives (OTC Pink : BDPTD) a annoncé le lancement national de Pawpa™ Regen, un complément révolutionnaire pour chiens conçu pour favoriser la guérison régénérative par l'activation des cellules souches chez les chiens âgés. Après un lancement limité réussi, le produit sera disponible à l'échelle nationale via des plateformes de commerce électronique d'ici fin juillet 2025.
La formule exclusive agit en stimulant la libération de cellules souches circulantes, ce qui améliore la vitalité, la mobilité et le bien-être général des chiens plus âgés. Les premiers tests ont montré des résultats positifs sur les niveaux d'énergie, la santé du pelage, la mobilité et le tempérament. L'entreprise augmente sa production pour répondre à la forte demande prévue sur le marché du bien-être animal.
BioAdaptives (OTC Pink: BDPTD) gab die landesweite Einführung von Pawpa™ Regen bekannt, einem revolutionären Nahrungsergänzungsmittel für Hunde, das die regenerative Heilung durch Aktivierung von Stammzellen bei älteren Hunden fördert. Nach einem erfolgreichen begrenzten Markteintritt wird das Produkt bis Ende Juli 2025 landesweit über E-Commerce-Plattformen erhältlich sein.
Die proprietäre Formel wirkt, indem sie die Freisetzung zirkulierender Stammzellen stimuliert, was zu Verbesserungen in Vitalität, Mobilität und allgemeinem Wohlbefinden bei älteren Hunden führt. Erste Tests zeigten positive Ergebnisse bei Energielevel, Fellgesundheit, Mobilität und Temperament. Das Unternehmen baut die Produktion aus, um der erwarteten starken Nachfrage im Markt für Haustier-Wellness gerecht zu werden.
- Successful limited market release with demonstrated positive results
- Product addresses unmet need in growing pet wellness market
- Multiple e-commerce distribution channels secured for national launch
- Proprietary formula with unique stem cell activation mechanism
- None.
Revolutionary Canine Supplement Promotes Regenerative Healing Through Stem Cell Activation
LAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC Pink: BDPT), an innovator in nutraceutical and wellness science, today announces the upcoming national release of Pawpa™ Regen, a proprietary canine supplement that supports natural stem cell activation and regenerative healing in aging dogs.
After a successful limited market release earlier this year, Pawpa™ Regen officially launches nationwide at the end of July 2025. This breakthrough formula stimulates the release of circulating stem cells, resulting in improved vitality, responsiveness, mobility, behavior, and appearance in older dogs.
“We’ve seen extraordinary improvements in energy levels, coat health, mobility and even temperament,” said James Keener, CEO at BioAdaptives. “Pawpa™ Regen represents a novel approach to canine wellness by tapping into the body’s regenerative potential through naturally sourced, safe ingredients.”
Pawpa™ Regen’s unique mechanism centers on mobilizing endogenous stem cells—a process that supports the repair of tissues, joints, and other systems affected by aging. Dog owners participating in the limited release have reported visible transformation in their pets, including:
- Increased enthusiasm and alertness
- Improved gait and movement
- Brighter eyes and a healthier coat
- Positive shifts in temperament and sociability
“This is about the quality of life for our aging pets,” said Keener. “Pawpa™ Regen fills a critical gap in the pet wellness market by delivering cutting-edge science in a safe, accessible, and natural formulation.”
The national release will include availability through multiple direct-to-consumer e-commerce platforms.
BioAdaptives anticipates strong demand based on early feedback and is scaling production accordingly. With pet owners seeking more holistic, science-based solutions for longevity and vitality, Pawpa™ Regen is poised to become a leading product in the canine wellness and anti-aging segment.
About BioAdaptives, Inc.
BioAdaptives, Inc. develops and markets science-based natural health and wellness products for both humans and animals. Its formulations leverage cutting-edge research in stem cell biology, adaptogens, and regenerative nutrition. The company’s mission is to enhance the quality of life through innovation that works in harmony with the body’s natural processes.
For more information, visit: www.bioadaptives.com
Contact:
Emily Harrison
Investor Relations
BioAdaptives, Inc.
(702) 659-8829
info@bioadaptives.com
Wire Service Contact:
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com
FAQ
When will BioAdaptives (BDPTD) launch Pawpa™ Regen nationwide?
What are the main benefits of BioAdaptives' Pawpa™ Regen supplement for dogs?
How does BioAdaptives' Pawpa™ Regen work for aging dogs?
Where will BioAdaptives' Pawpa™ Regen be available for purchase?
